Navigation Links
Ph.D. thesis shows why patients subjected to dialysis face their illness in different ways

Patients who have to undergo dialysis see their lives inevitably affected by the treatment. Despite medical advances, the quality of life perceived by these kidney patients has improved very little, although it varies from person to person. Basing this as her starting point, Dr Begoa Ruiz de Alegra studied the emotional progress of patients treated with dialysis (hospitalised haemodialysis treatment and domiciliary peritoneal dialysis) in the Basque Country Autonomous Community. She was able to identify the factors influencing this emotional progress and conclude that not all patients assimilate their illness in the same way results which will help to establish future treatment and enhance the quality of life of these patients. Her thesis, defended at the University of Basque Country (UPV/EHU), was entitled, Living with dialysis. Confronting it and quality of life.

The results of the research reveal a process of the patient facing up to the illness in a dynamic manner. According to Dr Ruiz de Alegra, the start of dialysis involves an impact that is initially dealt with through an emotional catharsis, then the emotions begin to be regulated, after six months the situation can be processed cognitively and, finally, after a year, a more active and instrumental dealing with the situation is adopted.

Introspection or adaptation

The way in which each patient responds during this process and perceives their illness and quality of life varies notably. Two ways of confronting the illness are described: deliberate introspection and deliberate adaptation. Introspection involves the amplification of negative emotional states in the medium term: patients think about how things might be without dialysis, setting themselves unrealistic targets (and being self-critical on not reaching them), and avoid being with other people. These are persons who have weaker emotional networks and live with greater stress.

The exact opposite occurs with those who respond with deliberate adaptation: they live with less stress under dialysis and the good social support network which they have is key to their better emotional progress. In fact, they have more trust in others and are able to face up to the experience they are going through with greater positivism.

The role of the family is important

The personal resources (the cognitive, emotional and psychological elements) which each patient has condition the way in which the illness is confronted and quality of life is perceived. But so do contextual factors or external resources, such as the previously mentioned social support. Ms Ruiz de Alegra particularly highlighted good family support, as this helps to lessen the negative perception of the patient with respect to the repercussions of the chronic illness and to facilitate management of emotional unwellness.

Professional support and the concomitant doctor-patient relationship is also important, especially as regards willingness to accept treatment.

Better with peritoneal dialysis

The method of dialysis to which the patient is subjected also has repercussions on him or her. This is one of the most novel conclusions of the PhD thesis, having enabled the demonstration of hitherto undescribed differences between haemodialysis and peritoneal dialysis, from a health psychology perspective.

Haemodialysis is an in-hospital treatment which treats the blood directly, while peritoneal dialysis can be carried out by the patient in his or her own home, involving infiltrating the dialysis liquid into the peritoneal cavity by means of a catheter. The research concludes that, a year after initiation of treatment, patients on haemodialysis indicate less satisfaction, freedom and control over their lives than those on peritoneal dialysis. Thus, it was concluded that peritoneal dialysis has a less negative impact on the lives of persons than haemodialysis.


Contact: Amaia Portugal
Elhuyar Fundazioa

Related medicine news :

1. AnaLisa DiFeo, Ph.D., recognized with the Liz Tilberis Scholarship
2. NTU and A*STAR launch joint Ph.D. research program in immunology
3. Differences between women and men with a primary psychotic episode analyzed in a Ph.D. thesis
4. Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist
5. Savvy Mom TV™ Welcomes Dr. Cynthia R. Green, Ph.D. as their Brain Health Expert
6. Mount Sinai first in US to implant aortic valve prosthesis to treat severe aortic stenosis
7. Masters student takes top thesis competition while tackling prostate cancer research
8. Researchers advance biosynthesis of potent anti-cancer drug Taxol
9. Thesis investigates characteristics of society using sports activities as research tool
10. Prosthesis with information at its fingertips
11. New studies question vascular multiple sclerosis hypothesis and treatment
Post Your Comments:
(Date:11/26/2015)... ... ... The Catalent Applied Drug Delivery Institute today announced a ... selection in early phase drug development. The first of these is to be ... UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, Oxford, ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... medical opinion process, participated in the 61st annual Employee Benefits Conference. The Employee ... took place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was ...
(Date:11/26/2015)... ... November 26, 2015 , ... Indosoft Inc., developer and ... an application server to improve system efficiency and reliability. , The new Q-Suite 6 ... these standards, the system avoids locking itself into a specific piece of software for ...
(Date:11/25/2015)... ... , ... The holiday season is jam-packed with family dinners, ... attendees is of the utmost importance. Whether you are cooking at home for ... a try this holiday season. , Turkey Croquettes ,     Ingredients: , ...
(Date:11/25/2015)... ... 2015 , ... TyloHelo Inc , North America’s largest ... accessories help improve the bather experience in the sauna, and the accessories selected ... purist looking for simplicity in design to accessories that encourage a greater expression ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 25, 2015 Allergan plc (NYSE: ... Rugen Therapeutics, a start-up  biotechnology company focused on ... disorders and funded by the F-Prime Biomedical Research ... into an exclusive collaboration to support the discovery ... Disorders (ASD) and Obsessive Compulsive disorders (OCD). ...
(Date:11/25/2015)... 2015 USP 800 applies to all ... pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home ... also covers all entities which store, prepare, transport, ... healthcare institutions, patient treatment clinics, physicians, practice facilities, ... --> What is the purpose of ...
(Date:11/25/2015)... 2015 Asia -based ... BioLight and the New Investors will make a direct ... a private placement. The financing will help IOPtima to ... used in the treatment of glaucoma, as well as ... IOPtimate™ system with the U.S. Food and Drug Administration, ...
Breaking Medicine Technology: